Purchase Order 75F40121P00526
- Not listed
- The U.S. Department of Health and Human Services Food and Drug Administration (HHS/FDA) awarded a Firm Fixed Price purchase order to Univercells Technologies, a foreign-owned for-profit organization, for the purchase of a Scale-X Carbo Cell Culture Bioreactor System and consumables. The contract, which has a Coronavirus COVID-19 National Interest Action Code, is valued at $245,730.00 and has a completion date of February 15, 2021. The contract was awarded on September 18, 2020 and was not set...
- This is a firm fixed-price purchase order awarded by the Defense Health Agency (DHA) to Univercells Technologies, a foreign-owned, for-profit corporate entity registered in SAM.gov. The contract, valued at $268,873.00, is for the purchase of a CARBO bioreactor system and associated services, including on-site system startup assistance, installation, site acceptance testing, qualification, and training. The bioreactor equipment is intended for cultivating viral microorganisms, supporting the...
- This is a $102,434 firm fixed-price purchase order awarded by the U.S. Department of the Interior (DOI) Fish and Wildlife Service Region 5 to Univercells Technologies, a Belgian manufacturer of biotechnology equipment. The contract is for the supply of a MA-ARD-ECOL SVCS WNS BIOREACTOR PURCHASE and has a period of performance through March 28, 2026. There is no set-aside designation for this award. Univercells Technologies is a subsidiary of the Belgian biotechnology company Univercells SA and...
- This is a $408,692 firm fixed-price definitive contract awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Univercells SA, a for-profit organization located in Belgium. The contract is for research and development of mRNA vaccine production using Univercells' NFINITYTM platform, under Advance Opportunity Inquiry (AOI) #21 "Vaccine on Demand: R&D for mRNA Production Reinvented." The contract has an ultimate completion date...
- The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $205,503.40 firm fixed price purchase order contract to Sartorius Stedim North America Inc., a foreign-owned for-profit organization, to provide a Biostat B-DCU 2-fold MO 120V fermenter/bioreactor system. This award was made on a competitive basis under FAR Part 12 - Acquisition of Commercial Items and FAR Part 13 - Simplified Acquisition Procedures, with no...
- This federal contract award, HHSF223201610523P, was issued by the Food and Drug Administration (FDA) to Repligen Corporation, a for-profit manufacturer of advanced bioprocessing equipment. The $105,364.76 firm fixed-price purchase order is for the delivery of bioreactor parts and Repligen's ATF (Alternating Tangential Flow) devices, which are critical components used in biopharmaceutical manufacturing processes such as vaccine development. The contract has a Total Small Business set-aside...
- The Food and Drug Administration (FDA) awarded a $465,096.00 firm fixed-price purchase order to Global Life Sciences Solutions USA LLC for the delivery of an XDR-50 single use bioreactor system or equivalent with accessories, training, and installation. The bioreactor system will support the FDA's Center for Drug Evaluation and Research Division of Product Quality Research. The contract has a two-year manufacturer's warranty and a performance period through May 18, 2025. This award was not set...
- This is a firm fixed-price purchase order contract awarded by the Food and Drug Administration (FDA) to Global Life Sciences Solutions USA LLC, a provider of technologies and services that advance the development and manufacture of therapeutics. The $84,557.26 contract is for the provision of an XURI Cell Expansion W25 bioreactor system. This equipment is likely being acquired to support the FDA's biomedical research and laboratory operations. Global Life Sciences Solutions has a history of...
- This is a firm fixed-price purchase order awarded by the Food and Drug Administration (FDA), a civilian federal agency, to Bioexpress, LLC, a for-profit limited liability company, for the delivery of a bead-based homogenizer with accessories. The contract has a ceiling value of $10,076.48 and a completion date of September 26, 2014. It is not associated with any larger contracting vehicle and does not have a set-aside designation. Bioexpress, LLC is the prime contractor, and no subcontractors...
- This is a $229,200.00 firm-fixed-price purchase order awarded by the Food and Drug Administration (FDA) to Unchained Labs, LLC, doing business as Optim, a for-profit biotechnology manufacturer. The contract, which has a set-aside for small businesses, is for the delivery of the "FFPHUNK PROTEIN PLATFORM" to support the FDA's "HUNK PROTEIN STABILITY PLATFORM" program. Unchained Labs specializes in advanced scientific instrumentation, equipment, and services for government...
This $89,630.00 firm fixed-price purchase order was awarded by the Department of Health and Human Services Food and Drug Administration (HHS/FDA) to Univercells Technologies, a foreign-owned, for-profit corporation, to provide UniverCells Bioreactor Consumables. The award was made in response to a pre-solicitation posted by the FDA on June 7, 2021, seeking sources for these bioreactor consumables. The award has an ultimate completion date of November 1, 2021 and was not set aside for any specific business type. Univercells Technologies is a subsidiary of the Belgium-based biotechnology company Univercells SA, which specializes in biomanufacturing solutions and has received previous prime contract awards and subcontracts from federal agencies for its bioreactor systems and related equipment.
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
UniverCells Bioreactor Consumables | FDA-CSS-1242528 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Solicitation 2/2 | 7/22/21, 3:56 PM | |
UniverCells Bioreactor Consumables | FDA-SSN-1242528 | Department of Health and Human Services Food and Drug Administration Office of Acquisition and Grant Services | Pre-Solicitation 1/2 | 6/7/21, 6:46 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $89.6k | 9/1/21 |